SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-084723
Filing Date
2018-03-16
Accepted
2018-03-16 06:06:03
Documents
4
Period of Report
2018-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481175d8k.htm 8-K 21122
2 EX-1.1 d481175dex11.htm EX-1.1 153149
3 EX-5.1 d481175dex51.htm EX-5.1 7058
4 EX-99.1 d481175dex991.htm EX-99.1 6807
  Complete submission text file 0001193125-18-084723.txt   189319
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 18694102
SIC: 2834 Pharmaceutical Preparations